These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10513621)

  • 1. Topical delivery system of ophthalmic drugs by periocular injection with viscous solution.
    Sasaki H; Kashiwagi S; Mukai T; Nishida K; Nakamura J; Nakashima M; Ichikawa M
    Biol Pharm Bull; 1999 Sep; 22(9):961-5. PubMed ID: 10513621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug absorption behavior after periocular injections.
    Sasaki H; Kashiwagi S; Mukai T; Nishida K; Nakamura J; Nakashima M; Ichikawa M
    Biol Pharm Bull; 1999 Sep; 22(9):956-60. PubMed ID: 10513620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic prediction of the ocular absorption of an instilled drug with ophthalmic viscous vehicle.
    Sasaki H; Yamamura K; Mukai T; Nishida K; Nakamura J; Nakashima M; Ichikawa M
    Biol Pharm Bull; 2000 Nov; 23(11):1352-6. PubMed ID: 11085365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular absorption behavior of palmitoyl tilisolol, an amphiphilic prodrug of tilisolol, for ocular drug delivery.
    Kawakami S; Nishida K; Mukai T; Yamamura K; Kobayashi K; Sakaeda T; Nakamura J; Nakashima M; Sasaki H
    J Pharm Sci; 2001 Dec; 90(12):2113-20. PubMed ID: 11745770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ ocular absorption of tilisolol through ocular membranes in albino rabbits.
    Sasaki H; Ichikawa M; Kawakami S; Yamamura K; Nishida K; Nakamura J
    J Pharm Sci; 1996 Sep; 85(9):940-3. PubMed ID: 8877883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-side-coated insert as a unique ophthalmic drug delivery system.
    Sasaki H; Nagano T; Sakanaka K; Kawakami S; Nishida K; Nakamura J; Ichikawa N; Iwashita J; Nakamura T; Nakashima M
    J Control Release; 2003 Oct; 92(3):241-7. PubMed ID: 14568405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained ocular delivery of tilisolol to rabbits after topical administration or intravitreal injection of lipophilic prodrug incorporated in liposomes.
    Kawakami S; Yamamura K; Mukai T; Nishida K; Nakamura J; Sakaeda T; Nakashima M; Sasaki H
    J Pharm Pharmacol; 2001 Aug; 53(8):1157-61. PubMed ID: 11518027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of ocular pharmacokinetics of tilisolol after instillation into anesthetized rabbits.
    Sasaki H; Yamamura K; Mukai T; Nishida K; Nakamura J; Nakashima M; Ichikawa M
    Biol Pharm Bull; 1999 Nov; 22(11):1253-5. PubMed ID: 10598041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iganidipine, a new water-soluble Ca2+ antagonist: ocular and periocular penetration after instillation.
    Ishii K; Matsuo H; Fukaya Y; Tanaka S; Sakaki H; Waki M; Araie M
    Invest Ophthalmol Vis Sci; 2003 Mar; 44(3):1169-77. PubMed ID: 12601046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of ocular pharmacokinetics of beta-blockers using a diffusion model after instillation.
    Yamamura K; Sasaki H; Nakashima M; Ichikawa M; Mukai T; Nishida K; Nakamura J
    Pharm Res; 1999 Oct; 16(10):1596-601. PubMed ID: 10554103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled release and ocular absorption of tilisolol utilizing ophthalmic insert-incorporated lipophilic prodrugs.
    Kawakami S; Nishida K; Mukai T; Yamamura K; Nakamura J; Sakaeda T; Nakashima M; Sasaki H
    J Control Release; 2001 Oct; 76(3):255-63. PubMed ID: 11578740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of propranolol in periocular tissues: a comparison of topical and systemic administration.
    Hao J; Yang MB; Liu H; Li SK
    J Ocul Pharmacol Ther; 2011 Oct; 27(5):453-9. PubMed ID: 21810027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periocular Tissue Concentrations of Propranolol after Ocular Instillation of a Gel-Forming Solution.
    Yang MB; Liu H; Li SK; Hao J
    Curr Drug Deliv; 2016; 13(7):1144-1151. PubMed ID: 26666297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periocular routes for retinal drug delivery.
    Raghava S; Hammond M; Kompella UB
    Expert Opin Drug Deliv; 2004 Nov; 1(1):99-114. PubMed ID: 16296723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ophthalmic preservatives as absorption promoters for ocular drug delivery.
    Sasaki H; Nagano T; Yamamura K; Nishida K; Nakamura J
    J Pharm Pharmacol; 1995 Sep; 47(9):703-7. PubMed ID: 8583378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of intraocular drug delivery by periocular injections using ocular fluorophotometry.
    Ghate D; Brooks W; McCarey BE; Edelhauser HF
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2230-7. PubMed ID: 17460284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dosing protocol on distribution of propranolol in periocular tissues after topical ocular instillation.
    Liu H; Yang MB; Li SK; Hao J
    Curr Eye Res; 2015 May; 40(6):638-45. PubMed ID: 25167079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved ocular: systemic absorption ratio of timolol by viscous vehicle and phenylephrine.
    Kyyrönen K; Urtti A
    Invest Ophthalmol Vis Sci; 1990 Sep; 31(9):1827-33. PubMed ID: 2211028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and posterior segment biodistribution of ESBA105, an anti-TNF-alpha single-chain antibody, upon topical administration to the rabbit eye.
    Furrer E; Berdugo M; Stella C; Behar-Cohen F; Gurny R; Feige U; Lichtlen P; Urech DM
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):771-8. PubMed ID: 18757508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular Penetration and Pharmacokinetics of Ripasudil Following Topical Administration to Rabbits.
    Isobe T; Kasai T; Kawai H
    J Ocul Pharmacol Ther; 2016 Sep; 32(7):405-14. PubMed ID: 27463221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.